Patents by Inventor Jacqueline M. Applegate

Jacqueline M. Applegate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6251350
    Abstract: The present invention relates to an improved process for the preparation of thiophosphoryl chloride which is useful as an intermediate for the synthesis of insecticidally active compounds. The improvement comprises the presence in the reaction mixture of a catalytic amount of a nitroxide free radical of the following general formula: wherein R1, R2, R3 and R4 represent an alkyl group.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: June 26, 2001
    Assignee: Bayer Corporation
    Inventors: Jacqueline M. Applegate, Peter E. Newallis, Vidyanatha A. Prasad
  • Patent number: 5895818
    Abstract: The present invention relates to a process for making N-(4-fluorophenyl)-N-(1-methylethyl)-2-?(5-trifluoromethyl)-1,3,4-thiadiaz ol-2-yl)oxy!acetamide in an aprotic, aromatic solvent. The process includes the steps of: (a) reacting 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole with N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in the presence of an aprotic, aromatic solvent to form an aqueous phase and an organic phase; (b) acidifying the phases, (c) separating the phases; and (d) recovering the N-(4-fluorophenyl)-N-(1-methylethyl)-2-?(5-trifluoromethyl)-1,3,4-thiadiaz ol-2-yl)oxy!acetamide from the organic phase.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: April 20, 1999
    Assignee: Bayer Corporation
    Inventors: Vidyanatha A. Prasad, Peter E. Newallis, Daniel M. Wasleski, Jacqueline M. Applegate, Klaus Jelich
  • Patent number: 5856499
    Abstract: The present invention provides a process for making thiadiazole sulfones. The present process is used to make 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole. 2-(Methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole is made using catalytic oxidation in the presence of a suitable oxidizing agent. The catalyst used for the oxidation reaction is glacial acetic acid.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: January 5, 1999
    Assignees: Bayer Corporation, Bayer Aktiengesellschaft
    Inventors: Vidyanatha A. Prasad, Jacqueline M. Applegate, Klaus Jelich, Achim Noack
  • Patent number: 5808152
    Abstract: The present invention relates to a process for making N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The process includes the steps of (a) reacting 2-chloro-N-(4-fluorophenyl)-N-(1-methylethyl)acetamide with sodium formate to form a reaction mixture that contains N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamideformate; (b) adding an aprotic, aromatic solvent to the reaction mixture; (c) hydrolyzing the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamideformate in the reaction mixture and (d) recovering N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide from the organic phase.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: September 15, 1998
    Assignee: Bayer Corporation
    Inventors: Vidyanatha A. Prasad, Jacqueline M. Applegate, David T. Erdman, Peter E. Newallis
  • Patent number: 5792872
    Abstract: The present invention relates to a process for making N-(4-fluorophenyl)-N-(1-methylethyl)-2-?(5-(trifluoromethyl)-1,3,4-thiadia zol-2-yl)oxy!acetamide, which process includes the steps of reacting 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4,-thiadiazole with N-(4-fluorophenyl)-2-hydroxy-N(1-methylethyl)acetamide in an aprotic, aromatic solvent with aqueous alkali to form an aqueous phase and an organic phase, separating the aqueous and organic phases and recovering the N-(4-fluorophenyl)-N-(1-methylethyl)-2-?(5-(trifluoromethyl)-1,3,4-thi adiazol-2-yl)oxy!acetamide from the organic phase. A preferred solvent and aqueous alkali are toluene and aqueous sodium hydroxide, respectively.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: August 11, 1998
    Assignee: Bayer Corporation
    Inventors: Vidyanatha A. Prasad, Jacqueline M. Applegate, Daniel M. Wasleski, Klaus Jelich
  • Patent number: 5756752
    Abstract: Substituted oxadiazolones of the formula (I) ##STR1## in which R represents optionally substituted alkyl, are obtained in good yields and high purity on reacting in a first step carboxylic acids of the general formula (II)R--COOH (II)with hydrazine hydrate in the presence of a catalyst and an inert diluent at temperatures between 0.degree. C. and 150.degree. C. with elimination of water and removal of said catalyst and reacting the resulting carboxylic hydrazides of the general formula (III)R--CO--NH--NH.sub.2 (III)in a second step with phosgene (COCl.sub.2) at temperatures between 20.degree. C. and 120.degree. C.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: May 26, 1998
    Assignees: Bayer Corporation, Bayer Aktiengesellschaft
    Inventors: Hans Joachim Diehr, Reinhard Lantzsch, Jacqueline M. Applegate, Klaus Jelich
  • Patent number: 5464600
    Abstract: Disclosed herein is an improved process for preparing a thiophosphoryl chloride comprising reacting sulfur with a phosphorous trichloride, the improvement comprising a catalytic amount of a tertiary amine catalyst.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: November 7, 1995
    Assignee: Bayer Corporation
    Inventors: Peter E. Newallis, Vidyanatha A. Prasad, Jacqueline M. Applegate